Janus Henderson Group Adds $209M in Astera Labs, Inc. ($ALAB)

Janus Henderson significantly increased its position in Astera Labs, Inc., now holding 433,165 shares.

Editorial illustration for Astera Labs, Inc. (ALAB)

Key Points

  • Janus Henderson boosted its stake in Astera Labs by 3,696%, adding 421,755 shares to reach a total of 433,165 shares valued at about $171 million.
  • Astera Labs trades on the NasdaqGS under the ticker ALAB, with a market cap of approximately $66.7 billion and a high P/E ratio of 263.
  • Insider trades included planned and unplanned transactions, while analysts from Evercore, Barclays, and others maintained their ratings with targets ranging from $200 to $297.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Janus Henderson Group significantly increased its investment in Astera Labs, Inc. (NasdaqGS: ALAB), according to its latest 13F filing with the SEC. The fund added 421,755 shares, boosting its stake by an impressive 3,696% to 433,165 shares, now valued at approximately $171 million. This filing reflects holdings as of the reporting period and might not represent Janus Henderson's current position.

What Changed in Janus Henderson's Astera Labs Position

Janus Henderson's position in Astera Labs saw a substantial increase, as the firm added 421,755 shares to its holdings. This move took its total to 433,165 shares from a previous 11,410 shares, marking a 3,696% boost. The reported value of this stake is about $171 million, suggesting a strong vote of confidence in the semiconductor solutions provider.

Other Institutional Activity in Astera Labs

Other major funds also adjusted their positions in Astera Labs. FMR LLC increased its holdings by 194,944 shares, ending with 25,529,885 shares valued at roughly $2.8 billion. BlackRock, Inc., however, reduced its stake by 1,519,089 shares, leaving it with 11,449,769 shares worth about $1.25 billion. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both reported new positions, each holding 7,309,778 and 6,340,732 shares valued at approximately $801 million and $695 million, respectively. Atreides Management, LP more than doubled its stake, adding 1,754,593 shares for a total of 3,365,787 shares valued at $369 million.

Astera Labs, Inc. Stock Up 70.8%

Shares of Astera Labs (NasdaqGS: ALAB) recently traded at around $394.87. The company boasts a market cap of approximately $66.7 billion, with a high P/E ratio of 263 and a forward P/E of 92.5. The stock has experienced a 52-week range between $84.78 and $398.13. Astera Labs' beta is high at 3.963, indicating significant volatility. It maintains a robust current ratio of 11.3 and a quick ratio of 10.55, with a debt-to-equity ratio of 2.801.

Year to date

$ALAB stock price

Daily closing prices, year to date. Not investment advice.

Recent Earnings

Astera Labs reported revenue of about $1 billion, with a notable growth rate of 93.4%. The company's net margin stands at 26.7%, and it achieved a return on equity of 21.1%. Earnings per share were $1.48. Investors can look forward to the next earnings report scheduled for August 4, 2026.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

B- 71/100

Reported May 5, 2026

  1. Forward outlook

    10 analysts raised price targets.

  2. EPS & revenue

    EPS beat estimates by 11.6%. Revenue beat estimates by 3.5%.

  3. Profit surprise

    EBITDA missed by 34 percent. Operating income missed by 40 percent.

  4. Pre-earnings setup

    Bar was high, analysts already very bullish.

  5. Analyst signal

    10 target raises.

  6. Earnings quality

    Gross margin up 1.4 points. Operating margin up 13.0 points.

Earnings Call Summary

Astera Labs delivered strong Q1 results with revenue of $308 million, up 93 percent year over year, driven by broad growth across signal conditioning and fabric switch products. PCIe Gen 6 products contributed over one third of total revenue. The company shipped initial production volumes of the new Scorpio X 320-lane switch and is expanding optical capabilities through the XScale acquisition, with near-package optics expected to ship in 2027 and chiplet-package optics in 2028.

Guidance Management expects revenue between $355 million and $365 million in the next quarter, up 15 to 18 percent sequentially. They expect non-GAAP earnings per share between $0.68 and $0.70, with gross margin around 73 percent before a one-time customer agreement charge. The Scorpio product line is expected to become their largest business by year end.

Slightly positive report. The quarter was acceptable, but the forward setup is not strong.

Insider Buying and Selling at Astera Labs, Inc.

Recent insider activity at Astera Labs includes a planned sale by Jack Lazar of 10,000 shares at an average price of $355.17 on June 4, 2026. On the same day, Craig Barratt, Michael Hurlston, Bethany Mayer, Jack Lazar, and Stefan Dyckerhoff each acquired 837 shares in unplanned transactions.

Analysts Set New Price Targets

Analysts have maintained their ratings on Astera Labs, with Evercore ISI Group reiterating a 'buy' rating and a $297 price target on May 19, 2026. Barclays kept a 'hold' rating with a $200 target on May 7, 2026. Other firms like JP Morgan, Citigroup, and Morgan Stanley also maintained 'buy' ratings with targets ranging from $240 to $280. The consensus recommendation remains a 'buy', with a mean price target of $244.97 based on 22 analyst opinions.

About Astera Labs

Astera Labs, Inc. is a technology company based in San Jose, California, specializing in semiconductor-based connectivity solutions for cloud and AI infrastructure. The company offers a range of products, including high-speed connectivity platforms and smart fabric switches, catering to hyperscalers and system OEMs. Led by CEO Mr. Jitendra Mohan, Astera Labs employs 756 people and was founded in 2017.

Bottom Line

Janus Henderson's significant increase in its stake in Astera Labs underscores the fund's confidence in the company's potential. While the 13F filing provides a snapshot of past holdings, it's a valuable tool for investors tracking institutional interest. Astera Labs continues to attract attention with its strong market position and robust financial performance.

Get Astera Labs, Inc. alerts

New 13F filings, insider trades, and analyst moves on $ALAB, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.